VentiRx Pharmaceuticals Secures $25,000,000 Series A Financing

  • Feed Type
  • Date
    1/12/2010
  • Company Name
    VentiRx Pharmaceuticals
  • Mailing Address
    12651 High Bluff Drive San Diego, CA 92130
  • Company Description
    VentiRx Pharmaceuticals, Inc. is a biopharmaceutical company committed to the development of novel medicines for the treatment of cancer, infectious, respiratory, and autoimmune diseases.
  • Website
    http://www.ventirx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $25,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    MedImmune Ventures
  • Venture Investor
    Frazier Healthcare Ventures
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Domain Associates

By posting a comment, you agree to our terms and conditions.